Aims & Scope:
Glucolipid Metabolic Disorders is an international, peer-reviewed, multi-disciplinary journal for
physicians, clinicians, and scientists with an interest in glucose and lipid metabolic
disorders in pathological processes, as well as the therapeutics targeting
these disorders to treat human diseases.
Glucolipid Metabolic Disorders publishes
original research articles, guidelines, reviews, and commentaries on a broad
range of topics. The journal is
particularly interested
in manuscripts that address important advances in glucolipid metabolomics and
the clinical application of targeting glucose and lipid metabolism. Areas of
interest cover, but are not limited to:
• Clinical applications of targeting glucose and lipid metabolism to improve patient care and outcomes
• Clinical trials illustrating the use of targeting glucose and lipid metabolism
• Conceptual characterization of glucolipid metabolic disorders
• Mechanisms of glucolipid metabolic disorders in diseases
• Metabolomics of glucose and lipids
• Methodologies & preclinical and clinical applications of glucolipid metabolomics
• Novel techniques & approaches for the advancement of glucolipid metabolomics
• Translational research in glucolipid metabolomics
Glucolipid Metabolic
Disorders is
an international, peer-reviewed journal on all aspects of glucolipid metabolomics,
published continuously
(print & online) by Bentham Science Publishers.
